Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Injection Sites: Systemic vs Local Comparison

Subcutaneous (abdomen, thigh, arm) 90–120 minutes Moderate (steady-state) 4–6 hours Gut healing, systemic inflammation, general tissue protection Standard for non-musculoskeletal goals—delivers consistent systemic levels without localized trauma risk Intramusc

This comparison does not assign a generated winner or score.

  • Subcutaneous (abdomen, thigh, arm)
  • 90–120 minutes
  • Moderate (steady-state)
  • 4–6 hours
  • Gut healing, systemic inflammation, general tissue protection
  • Standard for non-musculoskeletal goals—delivers consistent systemic levels without localized trauma risk
  • Intramuscular (near injury site)
  • 30–60 minutes
  • High (localized peak)
  • 3–4 hours
  • Tendon/ligament repair, muscle strains, joint injuries
  • Maximizes tissue concentration at injury zone—requires precise anatomical targeting
  • Intramuscular (distant site)
  • 45–90 minutes
  • Moderate
  • Systemic delivery when subcutaneous access is limited
  • Faster than subcutaneous but no localized benefit—rarely justified over abdomen injection
  • Oral (experimental only)
  • 120+ minutes
  • Very low (extensive first-pass metabolism)
  • 2–3 hours
  • Not clinically viable
  • Bioavailability too low for therapeutic effect—published studies use injectable routes exclusively
More references

Related material